A review on Sero diversity and antimicrobial resistance patterns of Shigella species in Africa, Asia and South America, 2001-2014
- PMID: 27576729
- PMCID: PMC5004314
- DOI: 10.1186/s13104-016-2236-7
A review on Sero diversity and antimicrobial resistance patterns of Shigella species in Africa, Asia and South America, 2001-2014
Abstract
Background: Shigella, gram negative bacterium, is responsible for Shigellosis/bacillary dysentery. It is a global concern although it predominates in developing countries. These are Shigella dysenteriae, Shigella flexneri, Shigella boydii and Shigella sonnei. Drug resistance by Shigella species is another headache of the world. Therefore; this study aimed to review distribution of Shigella Serogroups and their antimicrobial patterns carried out in Africa, Asia and South America.
Methods: A literature search was performed to identify published studies between January 2001 and December 2014. Published studies were identified using an initial search of the MEDLINE/Index Medicus Database, PubMed, Project Management Consultant, Google Scholar, Science Direct, BioMed Central and Index Copernicus.
Results: Shigella flexneri was isolated predominately from seven studies in four African countries and eight studies in five Asian countries. The countries in which eligible studies carried out were Ethiopia, Kenya, Eritrea and Ghana in Africa and Pakistan, Iran, China, Nepal and India in Asia. S. sonnei was isolated predominately from one study in Africa, four in Asia and two South America. The countries in which eligible studies carried out were Ethiopia from Africa, Thailand, Vietnam and Iran from Asia and Chile and Trinidad from South America. S. dysentery was also reported majorly from one eligible study in Egypt and one in Nepal. S. boydii did not score highest prevalence in any one of the eligible studies. Three studies from Africa, five from Asia and one from South America were reviewed for antimicrobial resistance patterns of Shigella Serogroups. In all the regions, Ampicillin developed highly resistance to almost all the Serogroups of Shigella whereas all the strains were sensitive to Ciprofloxacin.
Conclusion: The incidence of Shigella Serogroups in the selected three regions is different. The domination of S. flexneri is observed in Africa and Asia although S. sonnei in South America is dominant. Shigella Serogroups are becoming resistance to the commonly prescribed antimicrobial drugs in developing countries.
Keywords: Antimicrobial resistance; Serogroups of Shigella.
Similar articles
-
Prevalence of Shigella species and antimicrobial resistance patterns in Africa: systematic review and meta-analysis.BMC Infect Dis. 2024 Oct 29;24(1):1217. doi: 10.1186/s12879-024-09945-2. BMC Infect Dis. 2024. PMID: 39472797 Free PMC article.
-
Prevalence of Shigella serogroups and their antimicrobial resistance patterns in southern Trinidad.J Health Popul Nutr. 2008 Dec;26(4):456-62. doi: 10.3329/jhpn.v26i4.1889. J Health Popul Nutr. 2008. PMID: 19069625 Free PMC article.
-
Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004.J Microbiol Immunol Infect. 2008 Apr;41(2):107-11. J Microbiol Immunol Infect. 2008. PMID: 18473096
-
Frequency of isolation of shigella serogroups/serotypes and their antimicrobial susceptibility pattern in children from slum areas in Karachi.J Pak Med Assoc. 2005 May;55(5):184-8. J Pak Med Assoc. 2005. PMID: 15960281
-
Burden of Shigella in South Asia: a systematic review and meta-analysis.J Travel Med. 2023 Feb 18;30(1):taac132. doi: 10.1093/jtm/taac132. J Travel Med. 2023. PMID: 36331282
Cited by
-
Oral immunization with Shigella sonnei WRSs2 and WRSs3 vaccine strains elicits systemic and mucosal antibodies with functional anti-microbial activity.mSphere. 2024 Jan 30;9(1):e0041923. doi: 10.1128/msphere.00419-23. Epub 2023 Dec 22. mSphere. 2024. PMID: 38132716 Free PMC article.
-
Antimicrobial Resistance of Shigella flexneri in Pakistani Pediatric Population Reveals an Increased Trend of Third-Generation Cephalosporin Resistance.Curr Microbiol. 2022 Feb 27;79(4):118. doi: 10.1007/s00284-022-02805-9. Curr Microbiol. 2022. PMID: 35220467
-
Closed Genome and Comparative Phylogenetic Analysis of the Clinical Multidrug Resistant Shigella sonnei Strain 866.Genome Biol Evol. 2018 Sep 1;10(9):2241-2247. doi: 10.1093/gbe/evy168. Genome Biol Evol. 2018. PMID: 30060169 Free PMC article.
-
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.PLoS One. 2018 Mar 28;13(3):e0194325. doi: 10.1371/journal.pone.0194325. eCollection 2018. PLoS One. 2018. PMID: 29590182 Free PMC article.
-
Molecular characterization of quinolone resistant Shigella spp. isolates from patients in Ardabil, Iran.Iran J Microbiol. 2019 Dec;11(6):496-501. Iran J Microbiol. 2019. PMID: 32148681 Free PMC article.
References
-
- Baron S. Shigella. In: Hale TL, Keusch GT, editors. Baron’s medical microbiology. Galveston: University of Texas; 2000. - PubMed
-
- Mims C, Dockrell HM, Goering RV, Roit I, Wakelin D, Zukerman M. Medical microbiology. 3. Edinburgh: Elsevier; 2007.
-
- Center for diseases control, Bacterial Foodborne and Diarrheal Disease National Case Surveillance: Annual Report. Atlanta: USA; 2005. Department of Health and Human Services.
-
- European center for diseases control, Annual epidemiological report, 2013, reporting on 2011 surveillance data and 2012 epidemic intelligence data, Stockholm.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical